Document is current

Article History

Accepted: 13 September 2022

First Online: 7 November 2022

Declarations

:

: Dr. Roger McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Abbvie, and Atai Life Sciences. Dr. Roger McIntyre is a CEO of Braxia Scientific Corp.Dr. Joshua D Rosenblat has received research grant support from the Canadian Institute of Health Research (CIHR), Labatt Family Innovation Fund, Canadian Cancer Society, Canadian Psychiatric Association, Academic Scholars Award, American Psychiatric Association, American Society of Psychopharmacology, University of Toronto, University Health Network Centre for Mental Health, Joseph M. West Family Memorial Fund and Timeposters Fellowship and industry funding for speaker/consultation/research fees from Janssen, Allergan, Lundbeck, Sunovion, and COMPASS. He is the Chief Medical and Scientific Officer of Braxia Scientific and the medical director of Braxia Health (Canadian Rapid Treatment Centre of Excellence).Dr. Rodrigo B. Mansur has received research funding from the Canadian Institutes of Health Research, Physician Services Incorporated foundation, the Baszucki Brain Research Fund, and an Academic Scholar Award from the University of Toronto, Department of Psychiatry.All other authors have no conflicts of interest to disclose.

: This article does not contain any studies with human participants or animals performed by any of the authors.